Annual Short Term Debt
$660.70 K
+$22.10 K+3.46%
30 September 2022
Summary:
NeuBase Therapeutics annual short term debt is currently $660.70 thousand, with the most recent change of +$22.10 thousand (+3.46%) on 30 September 2022. During the last 3 years, it has risen by +$22.10 thousand (+3.46%).NBSE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$500.80 K
-$9400.00-1.84%
30 September 2023
Summary:
NeuBase Therapeutics quarterly short term debt is currently $500.80 thousand, with the most recent change of -$9400.00 (-1.84%) on 30 September 2023.NBSE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +3.5% | -21.6% |
| 5 y5 years | +437.6% | +307.5% |
NBSE Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -25.9% |
NeuBase Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $500.80 K(-1.8%) |
| June 2023 | - | $510.20 K(-3.6%) |
| Mar 2023 | - | $529.30 K(-3.4%) |
| Dec 2022 | - | $548.10 K(-17.0%) |
| Sept 2022 | $660.70 K(+3.5%) | $660.70 K(-2.2%) |
| June 2022 | - | $675.90 K(+2.2%) |
| Mar 2022 | - | $661.60 K(+22.3%) |
| Dec 2021 | - | $541.00 K(-15.3%) |
| Sept 2021 | $638.60 K(+360.8%) | $638.60 K(+12.3%) |
| June 2021 | - | $568.50 K(>+9900.0%) |
| Mar 2021 | - | $0.00(0.0%) |
| Dec 2020 | - | $0.00(-100.0%) |
| Sept 2020 | $138.60 K(+12.8%) | $138.60 K(-56.7%) |
| June 2020 | - | $320.40 K(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | - | $49.50 K(-59.7%) |
| Sept 2019 | $122.90 K(>+9900.0%) | $122.90 K(>+9900.0%) |
| June 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | - | $0.00(0.0%) |
| Sept 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2018 | - | $181.50 K(-37.0%) |
| Mar 2018 | - | $287.90 K(>+9900.0%) |
| Dec 2017 | - | $0.00(-100.0%) |
| Sept 2017 | $106.40 K(+21.2%) | $106.40 K(-32.9%) |
| June 2017 | - | $158.60 K(-39.3%) |
| Mar 2017 | - | $261.30 K(>+9900.0%) |
| Dec 2016 | - | $0.00(-100.0%) |
| Sept 2016 | $87.80 K(+82.5%) | $87.80 K(-33.0%) |
| June 2016 | - | $131.00 K(-39.3%) |
| Mar 2016 | - | $215.80 K(>+9900.0%) |
| Dec 2015 | - | $0.00(-100.0%) |
| Sept 2015 | $48.10 K | $48.10 K(-59.6%) |
| June 2015 | - | $119.20 K(-37.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $189.20 K(>+9900.0%) |
| Dec 2014 | - | $0.00(-100.0%) |
| Sept 2014 | $43.90 K(+211.3%) | $43.90 K(-59.7%) |
| June 2014 | - | $108.90 K(-43.9%) |
| Mar 2014 | - | $194.00 K(>+9900.0%) |
| Dec 2013 | - | $0.00(-100.0%) |
| Sept 2013 | $14.10 K(-35.9%) | $14.10 K(-66.7%) |
| June 2013 | - | $42.40 K(+1077.8%) |
| Mar 2013 | - | $3600.00(-52.0%) |
| Dec 2012 | - | $7500.00(-65.9%) |
| Sept 2012 | $22.00 K(>+9900.0%) | $22.00 K(-50.5%) |
| June 2012 | - | $44.40 K(-8.1%) |
| Mar 2012 | - | $48.30 K(>+9900.0%) |
| Sept 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $1700.00(-75.0%) |
| Dec 2010 | - | $6800.00(-61.1%) |
| Sept 2010 | $17.50 K(-90.3%) | $17.50 K(+6.1%) |
| June 2010 | - | $16.50 K(-32.7%) |
| Mar 2010 | - | $24.50 K(-90.2%) |
| Dec 2009 | - | $251.20 K(+39.6%) |
| Sept 2009 | $180.00 K(+390.5%) | $180.00 K(-21.7%) |
| June 2009 | - | $230.00 K(-5.7%) |
| Mar 2009 | - | $244.00 K(+55.4%) |
| Mar 2007 | - | $157.00 K(+349.9%) |
| Mar 2006 | - | $34.90 K(-4.9%) |
| Dec 2005 | $36.70 K(-20.0%) | $36.70 K(+23.2%) |
| Sept 2005 | - | $29.80 K(-29.9%) |
| June 2005 | - | $42.50 K(+22.8%) |
| Mar 2005 | - | $34.60 K(-24.6%) |
| Dec 2004 | $45.90 K(-5.0%) | $45.90 K(-4.6%) |
| Sept 2004 | - | $48.10 K(+8.1%) |
| June 2004 | - | $44.50 K(-2.6%) |
| Mar 2004 | - | $45.70 K |
| Dec 2003 | $48.30 K | - |
FAQ
- What is NeuBase Therapeutics annual short term debt?
- What is the all time high annual short term debt for NeuBase Therapeutics?
- What is NeuBase Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for NeuBase Therapeutics?
What is NeuBase Therapeutics annual short term debt?
The current annual short term debt of NBSE is $660.70 K
What is the all time high annual short term debt for NeuBase Therapeutics?
NeuBase Therapeutics all-time high annual short term debt is $660.70 K
What is NeuBase Therapeutics quarterly short term debt?
The current quarterly short term debt of NBSE is $500.80 K
What is the all time high quarterly short term debt for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly short term debt is $675.90 K